Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001120 · ClinicalTrials.gov registry record

A Study of Patients With AIDS Syndrome

A clinical trial of HIV Infections and Lymphoma, Non-Hodgkin, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Completed
Registry status
5,000
Enrollment target
20
Study locations

NCT00001120: Completed study of HIV Infections and Lymphoma, Non-Hodgkin, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

NCT00001120 is a study of HIV Infections and Lymphoma, Non-Hodgkin that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 5,000 participants, above the 437-participant average among 542 other HIV Infections trials with a reported enrollment target (1044% higher). The trial reports 20 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00001120, a study of HIV Infections and Lymphoma, Non-Hodgkin, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

COMPLETED
Registry status
5,000 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to find out why cancers develop in HIV-positive patients. Cancer is a leading cause of death in AIDS patients. Common cancers in HIV-infected patients include Kaposi's sarcoma (KS) and non-Hodgkin's lymphoma (NHL), a cancer of the immune system. Risk factors include certain chemicals, viruses, and perhaps even anti-HIV drugs. Doctors would like to find out which risk factors are most important and how they relate to cancer in AIDS patients.

Conditions Studied

HIV Infections Lymphoma, Non-Hodgkin Sarcoma, Kaposi Lymphoma, AIDS-Related

Study Locations (20)

California

  • Willow Clinic - Menlo Park
  • San Francisco Gen Hosp - San Francisco
  • Marin County Specialty Clinic - San Rafael
  • San Mateo AIDS Program / Stanford Univ - Stanford
  • Stanford Univ Med Ctr - Stanford

New York

  • SUNY / Erie County Med Ctr at Buffalo - Buffalo
  • Bellevue Hosp / New York Univ Med Ctr - New York
  • Mem Sloan - Kettering Cancer Ctr - New York
  • St Mary's Hosp (Univ of Rochester/Infectious Diseases) - Rochester
  • Univ of Rochester Medical Center - Rochester

Louisiana

  • Charity Hosp / Tulane Univ Med School - New Orleans
  • Tulane Univ School of Medicine - New Orleans

North Carolina

  • Univ of North Carolina - Chapel Hill
  • Duke Univ Med Ctr - Durham

Ohio

  • Univ of Cincinnati - Cincinnati
  • Case Western Reserve Univ - Cleveland

Hawaii

  • Univ of Hawaii - Honolulu

Indiana

  • Indiana Univ Hosp - Indianapolis

Maryland

  • Johns Hopkins Hosp - Baltimore

Trial Details

FieldValue
Enrollment Target 5,000 participants
National Institute of Allergy and Infectious Diseases (NIAID)

2,006 total trials

What the finished NCT00001120 record still lists

NCT00001120 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 437-participant average among 542 other HIV Infections trials with a reported enrollment target (1044% higher).

The record links to 4 conditions, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.

NCT00001120 names 20 study sites across 9 states, led by California, New York, Louisiana.

Frequently Asked Questions

What is clinical trial NCT00001120 about?

NCT00001120 is a clinical study titled "A Study of Patients With AIDS Syndrome". The purpose of this study is to find out why cancers develop in HIV-positive patients. Cancer is a leading cause of death in AIDS patients. Common cancers in HIV-infected patients include Kaposi's sarcoma (KS) and non-Hodgkin's lymphoma (NHL), a cancer of the immune system. Risk factors include cer...

What is the current status of trial NCT00001120?

This trial is currently completed. The enrollment target is 5,000 participants.

What conditions does trial NCT00001120 study?

This clinical trial studies the following conditions: HIV Infections, Lymphoma, Non-Hodgkin, Sarcoma, Kaposi, Lymphoma, AIDS-Related.

Who is sponsoring clinical trial NCT00001120?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00001120 being conducted?

This trial has 20 study locations across California, Hawaii, Indiana, Louisiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00001120's enrollment target sits among peer trials

5,000 5th of 542 higher than 537 of 542 other HIV Infections trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00060541 · 5,000 participants

    Evaluation and Treatment of Neurosurgical Disorders

  • NCT00575081 · 5,000 participants

    Physiological Brain Atlas Development

  • NCT00736749 · 5,000 participants

    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

  • NCT00900198 · 5,000 participants

    Collection of Tissue Samples for Cancer Research

Related registry views

Source: ClinicalTrials.gov NCT00001120, the US trial registry maintained by the National Library of Medicine. NCT00001120 (large enrollment · wide site footprint · completed) retrieved and formatted by PlainTrial, see methodology.